Jeff Lau

730 total citations
3 papers, 127 citations indexed

About

Jeff Lau is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jeff Lau has authored 3 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Jeff Lau's work include HER2/EGFR in Cancer Research (1 paper), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). Jeff Lau is often cited by papers focused on HER2/EGFR in Cancer Research (1 paper), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). Jeff Lau collaborates with scholars based in United States, Italy and Argentina. Jeff Lau's co-authors include John A. Flygare, Suchit Jhunjhunwala, Andrew G. Polson, MaryAnn Go, Bing Zheng, Michele Caruso, Susan D. Spencer, Robert Cohen, Helga Raab and Shang‐Fan Yu and has published in prestigious journals such as Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Jeff Lau

3 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Lau United States	2	100	82	38	13	13	3	127
Francesca Pettinella United States	4	75 0.8×	51 0.6×	29 0.8×	9 0.7×	11 0.8×	8	122
Eline M. Loosveld	3	149 1.5×	125 1.5×	39 1.0×	3 0.2×	10 0.8×	5	173
Mary Ann T. Go United States	5	50 0.5×	71 0.9×	31 0.8×	11 0.8×	10 0.8×	7	104
Lillian Skidmore Italy	5	157 1.6×	133 1.6×	47 1.2×	4 0.3×	15 1.2×	11	192
Carlos Hickey United States	5	59 0.6×	41 0.5×	36 0.9×	4 0.3×	25 1.9×	6	105
Katie E. Archer United States	6	114 1.1×	97 1.2×	89 2.3×	7 0.5×	10 0.8×	12	186
Laura Kist de Ruijter Netherlands	4	90 0.9×	90 1.1×	18 0.5×	4 0.3×	34 2.6×	5	161
Kevin Dang United States	6	131 1.3×	113 1.4×	36 0.9×	18 1.4×	62 4.8×	14	174
Sung-Ju Moon United States	3	153 1.5×	119 1.5×	77 2.0×	5 0.4×	13 1.0×	6	209
Shruti Tiwari United States	4	65 0.7×	20 0.2×	24 0.6×	4 0.3×	5 0.4×	13	110

Countries citing papers authored by Jeff Lau

Since Specialization

Citations

This map shows the geographic impact of Jeff Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Lau more than expected).

Fields of papers citing papers by Jeff Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Lau. The network helps show where Jeff Lau may publish in the future.

Co-authorship network of co-authors of Jeff Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Lau. A scholar is included among the top collaborators of Jeff Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Lau. Jeff Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Song, K S, Christy C. Ong, Jeff Lau, et al.. (2025). KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077). Molecular Cancer Therapeutics. 24(12). 1890–1901. 1 indexed citations

2.

Ravichandran, Mirunalini, Jeff Lau, Jennifer A. Lacap, et al.. (2025). Data from RIT1<sup>M90I</sup> Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy. 1 indexed citations

3.

Yu, Shang‐Fan, Bing Zheng, MaryAnn Go, et al.. (2015). A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs. Clinical Cancer Research. 21(14). 3298–3306. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact